CNTB (Connect Biopharma Holdings) Net Margin % : 31.72% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Connect Biopharma Holdings's Net Income for the six months ended in Jun. 2024 was $7.65 Mil. Connect Biopharma Holdings's Revenue for the six months ended in Jun. 2024 was $24.12 Mil. Therefore, Connect Biopharma Holdings's net margin for the quarter that ended in Jun. 2024 was 31.72%.

The historical rank and industry rank for Connect Biopharma Holdings's Net Margin % or its related term are showing as below:

CNTB' s Net Margin % Range Over the Past 10 Years
Min: -88.66 Med: 0 Max: 0
Current: -88.66

CNTB's Net Margin % is ranked better than
55.65% of 1017 companies
in the Biotechnology industry
Industry Median: -137.03 vs CNTB: -88.66

Connect Biopharma Holdings Net Margin % Historical Data

The historical data trend for Connect Biopharma Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Net Margin % Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial					-	-	-	-	31.72

Competitive Comparison of Connect Biopharma Holdings's Net Margin %

For the Biotechnology subindustry, Connect Biopharma Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Connect Biopharma Holdings's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's Net Margin % falls into.

Connect Biopharma Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Connect Biopharma Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-59.503	/	0
	=	%

Connect Biopharma Holdings's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	7.649	/	24.116
	=	31.72 %

Connect Biopharma Holdings (NAS:CNTB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Connect Biopharma Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.